These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17995974)

  • 41. Outcomes of dosage adjustments used to manage antiretroviral drug interactions.
    Park-Wyllie LY; Levine MA; Holbrook A; Thabane L; Antoniou T; Yoong D; Kam D; Bayoumi AM
    Clin Infect Dis; 2007 Oct; 45(7):933-6. PubMed ID: 17806064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Liver and antiretrovirals: hepatotoxicity, steatosis and monitoring of patients with liver disease].
    Bourlière M; Duclos-Vallée JC; Pol S
    Gastroenterol Clin Biol; 2007 Oct; 31(10):895-905. PubMed ID: 18166875
    [No Abstract]   [Full Text] [Related]  

  • 43. Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.
    Jiménez-Nácher I; Alvarez E; Morello J; Rodriguez-Nóvoa S; de Andrés S; Soriano V
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):457-77. PubMed ID: 21342079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Getting smarter--the toxicity of undertreated HIV infection.
    Currier JS; Baden LR
    N Engl J Med; 2006 Nov; 355(22):2359-61. PubMed ID: 17135590
    [No Abstract]   [Full Text] [Related]  

  • 45. [Inappropriate combinations of antiretroviral drugs].
    Machala L; Cerný R
    Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):241-3. PubMed ID: 15558454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and pharmacodynamics in HAART and antibiotic therapy.
    Boffito M
    New Microbiol; 2007 Jul; 30(3):346-9. PubMed ID: 17802923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Response regarding "HIV encephalopathy due to drug resistance despite 2-year suppression of HIV viremia by cART"].
    Sekiya H; Kawamoto M; Togo M; Yoshimura H; Imai Y; Kohara N
    Rinsho Shinkeigaku; 2015; 55(6):437. PubMed ID: 26103822
    [No Abstract]   [Full Text] [Related]  

  • 48. Drugs for HIV Infection.
    Treat Guidel Med Lett; 2009 Feb; 7(78):11-22. PubMed ID: 19172137
    [No Abstract]   [Full Text] [Related]  

  • 49. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV.
    Matza LS; Paulus TM; Garris CP; Van de Velde N; Chounta V; Deger KA
    Patient; 2020 Aug; 13(4):409-422. PubMed ID: 32356146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV survival benefit associated with earlier antiviral therapy.
    Mocroft A; Phillips AN; Lundgren JD
    Ann Intern Med; 2004 Apr; 140(7):578-9; author reply 579. PubMed ID: 15068990
    [No Abstract]   [Full Text] [Related]  

  • 51. Early versus deferred antiretroviral therapy for HIV.
    Hernán MA; Robins JM
    N Engl J Med; 2009 Aug; 361(8):822-3; author reply 823-4. PubMed ID: 19701984
    [No Abstract]   [Full Text] [Related]  

  • 52. Early versus deferred antiretroviral therapy for HIV.
    Gelinck LB; van der Ende ME
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701986
    [No Abstract]   [Full Text] [Related]  

  • 53. Early versus deferred antiretroviral therapy for HIV.
    Buchbinder SP; Jain V
    N Engl J Med; 2009 Aug; 361(8):822; author reply 823-4. PubMed ID: 19692695
    [No Abstract]   [Full Text] [Related]  

  • 54. Early versus deferred antiretroviral therapy for HIV.
    Arribas JR; Mora M; Pascual-Pareja JF
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701985
    [No Abstract]   [Full Text] [Related]  

  • 55. [Use of antiretroviral agents in cirrhotic patients infected by HIV].
    Salmon-Céron D
    Med Mal Infect; 2004 Nov; 34 Spec No 2():14-9. PubMed ID: 15801534
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacokinetic interactions between buprenorphine and antiretroviral medications.
    Bruce RD; McCance-Katz E; Kharasch ED; Moody DE; Morse GD
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S216-23. PubMed ID: 17109308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-drug interactions: antiretroviral drugs and recreational drugs.
    Staltari O; Leporini C; Caroleo B; Russo E; Siniscalchi A; De Sarro G; Gallelli L
    Recent Pat CNS Drug Discov; 2014; 9(3):153-63. PubMed ID: 25429704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
    Bucher HC; Wolbers M; Porter K
    JAMA; 2010 Nov; 304(17):1897; author reply 1897-8. PubMed ID: 21045094
    [No Abstract]   [Full Text] [Related]  

  • 59. Trial finds simultaneous HIV/tuberculosis treatment beneficial.
    Baleta A
    Lancet Infect Dis; 2008 Nov; 8(11):669. PubMed ID: 18992400
    [No Abstract]   [Full Text] [Related]  

  • 60. [Yes, simplify antiretroviral treatments, but not at a significant price!].
    Casalino E
    Med Mal Infect; 2005 Apr; 35 Suppl 1():S11-4. PubMed ID: 15922875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.